AZTR
Azitra Inc
NYSE MKT: AZTR · HEALTHCARE · BIOTECHNOLOGY
$0.25
+0.52% today
Updated 2026-04-29
Market cap
$3.56M
P/E ratio
—
P/S ratio
239.97x
EPS (TTM)
$-2.25
Dividend yield
—
52W range
$0 – $2
Volume
14.7M
Azitra Inc (AZTR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-6.54M | $-8.07M | $-8.35M | $-7.36M | $-10.18M | $-11.22M |
| Capital expenditures | $217687.00 | $652275.00 | $341011.00 | $318259.00 | $379246.00 | $24.21M |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | $306055.00 | $184465.00 | $151505.00 | $245053.00 | $62.74M |
| Free cash flow | $-6.76M | $-8.72M | $-8.69M | $-7.68M | $-10.56M | $-35.44M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |